Treatment for croup focuses on reducing airway inflammation and relieving breathing distress using dexamethasone and nebulized epinephrine. It's most effective when started early in the course of symptoms.
Croup is caused by viral infection-most often parainfluenza virus-that leads to swelling in the upper airway, particularly around the vocal cords. This causes a characteristic barking cough, hoarseness, and inspiratory stridor (a high-pitched sound when breathing in). Symptoms typically worsen at night and may require medical intervention if they interfere with oxygenation or cause significant work of breathing.
The American Academy of Pediatrics (AAP) recommends dexamethasone as first-line therapy due to its proven ability to reduce airway edema and prevent hospitalization. A single dose of 0.6 mg/kg oral or intramuscularly reduces symptom severity within 6 hours and maintains benefit for up to 48 hours. Dexamethasone is preferred over prednisolone because of its longer half-life and lower risk of rebound symptoms.
Dexamethasone suppresses inflammatory pathways in the larynx, decreasing mucosal swelling and narrowing of the airway. It acts rapidly-within 30 minutes-but peak effect occurs at 6 hours. The drug is well-absorbed orally and is effective even if administered at home after a diagnosis is confirmed.
Nebulized epinephrine provides immediate but short-term relief. It works through alpha-adrenergic receptor activation, causing vasoconstriction and reduction in subglottic edema. Effects begin within 15 minutes and last 1-2 hours. Because of this transient action, children treated with epinephrine must be monitored for recurrence of symptoms after the medication wears off.
A 2021 Cochrane review analyzed 14 randomized controlled trials involving over 1,500 children. It concluded that both dexamethasone and nebulized epinephrine reduced the need for hospital admission. Children receiving dexamethasone had a 30% lower risk of requiring hospitalization compared to placebo. Those who received epinephrine showed faster symptom improvement but were more likely to relapse within 2 hours.
Standard treatment protocols follow a tiered approach based on symptom severity:
| Symptom Severity | First-Line Treatment | Dosing & Route | Monitoring Needed |
|---|---|---|---|
| Mild (barking cough, hoarseness) | Dexamethasone | 0.6 mg/kg PO/IM | None beyond observation |
| Moderate (stridor at rest, retractions) | Dexamethasone + Nebulized epinephrine | 0.6 mg/kg dexamethasone; 5 mL 2.25% epinephrine in 2.5 mL saline | Observation for 2 hours post-treatment |
| Severe (cyanosis, severe retractions, altered mental status) | Emergency care | IV dexamethasone; 1:1000 epinephrine IM; intubation if needed | ICU monitoring |
For mild cases, dexamethasone alone is sufficient. In moderate cases, combining dexamethasone with nebulized epinephrine improves outcomes. A child with stridor at rest or visible chest wall retractions should receive both treatments and be observed for at least two hours after epinephrine administration.
One common misconception is that nebulized epinephrine can be used repeatedly. It should not be given more than once in a 24-hour period unless under direct supervision. Repeated doses increase risks of tachycardia, hypertension, and anxiety. Epinephrine is not a substitute for steroids-it complements them.
Many parents assume croup is a form of asthma. While both involve airway obstruction, croup affects the upper airway (larynx and trachea), whereas asthma primarily involves the lower airways (bronchioles). The barking cough and stridor are hallmarks of croup, not asthma. Using albuterol, a bronchodilator, will not improve croup symptoms and may delay appropriate care.
Another error is relying on home remedies like humidifiers. While cool mist may provide comfort, it does not reduce airway swelling. A 2019 study published in *Pediatrics* found no difference in symptom duration between children using cool mist versus room air. Humidifiers do not replace medical treatment.
I once observed a 3-year-old boy brought to the ER with worsening stridor after being given a vaporizer at home. His symptoms improved only after dexamethasone and nebulized epinephrine were administered. The family believed the vaporizer was helping, but it delayed access to effective treatment.
Emergency evaluation is required if a child shows signs of respiratory failure. These include:
Children with these signs may require intubation or have a higher risk of needing intensive care. The presence of drooling or inability to swallow suggests possible airway compromise and warrants immediate assessment.
Outpatient follow-up is recommended within 24-48 hours after treatment. If symptoms persist or worsen, a repeat evaluation is necessary. A child who remains febrile beyond 48 hours may have a secondary bacterial infection or an alternative diagnosis such as epiglottitis, which requires urgent imaging and antibiotics.
Effective treatment for croup centers on dexamethasone and, when indicated, nebulized epinephrine. Early administration prevents progression to severe respiratory distress. Steroids reduce inflammation, while epinephrine offers rapid but temporary relief. Neither should be used without proper indication or monitoring.